We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
-5.18%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.76B
AUM Growth
-$525M
(-16%)
Cap. Flow
-$439M
Cap. Flow
% of AUM
-15.9%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VRAY
ViewRay, Inc.
VRAY
|
+$17.9M |
| 2 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$17.3M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$14.1M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$14M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$12.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seer Inc
SEER
|
+$24.7M |
| 2 |
MAPS
WM TECHNOLOGY INC A
MAPS
|
+$23.4M |
| 3 |
LivaNova
LIVN
|
+$20.2M |
| 4 |
Glaukos
GKOS
|
+$17.5M |
| 5 |
Cooper Companies
COO
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.75% |
| 2 | Consumer Staples | 0.58% |
| 3 | Financials | 0.5% |
| 4 | Consumer Discretionary | 0.42% |
| 5 | Industrials | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PUT
Waters Corp
WAT
$40.7B
| $26.2M | 0.95% |
+70,300
| New | +$24.6M |
|
27
AtriCure
ATRC
$2.18B
| $26.2M | 0.95% |
376,131
-103,162
| -22% | -$7.5M |
|
28
PUT
DexCom
DXCM
$33.8B
| $23.3M | 0.84% |
173,200
-6,800
| -4% | -$977K |
|
|
QTNT
29
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $22.4M | 0.81% |
216,260
+69,765
| +48% | +$6.69M |
|
30
Natera
NTRA
$45.1B
| $22M | 0.8% |
235,199
-5,494
| -2% | -$570K |
|
|
31
CALL
Seer Inc
SEER
$119M
| $21.5M | 0.78% |
+944,400
| New | +$27.2M |
|
32
CALL
Vertex Pharmaceuticals
VRTX
$134B
| $21.3M | 0.77% |
97,000
-3,000
| -3% | -$583K |
|
33
Outset Medical
OM
$90.6M
| $20.9M | 0.76% |
30,214
-5,865
| -16% | -$4.34M |
|
|
CUTR
34
CALL
DELISTED
Cutera, Inc.
CUTR
| $20.4M | 0.74% |
492,800
+104,900
| +27% | +$4.3M |
|
35
CALL
Tenet Healthcare
THC
$20.9B
| $18.5M | 0.67% |
+226,700
| New | +$16.6M |
|
36
CALL
AMN Healthcare
AMN
$1.28B
| $18.4M | 0.66% |
150,000
-150,000
| -50% | -$16.7M |
|
37
CALL
Pulmonx
LUNG
$97.1M
| $18.1M | 0.66% |
+565,600
| New | +$20.7M |
|
38
PUT
Thermo Fisher Scientific
TMO
$224B
| $16.7M | 0.6% |
25,000
+15,000
| +150% | +$9.37M |
|
|
39
PUT
Cooper Companies
COO
$15B
| $16.5M | 0.6% |
+158,000
| New | +$16.1M |
|
40
PUT
Mettler-Toledo International
MTD
$28.8B
| $16.5M | 0.6% |
9,700
-300
| -3% | -$454K |
|
41
CALL
Establishment Labs
ESTA
$2.21B
| $16.4M | 0.6% |
+243,300
| New | +$17M |
|
42
CALL
ICU Medical
ICUI
$4.55B
| $16.4M | 0.59% |
69,000
-71,000
| -51% | -$16.6M |
|
|
43
Pulmonx
LUNG
$97.1M
| $15.4M | 0.56% |
480,088
-361,676
| -43% | -$13.2M |
|
44
PUT
CONMED
CNMD
$1.48B
| $15.4M | 0.56% |
+108,400
| New | +$15.4M |
|
45
CALL
Celldex Therapeutics
CLDX
$3.48B
| $15.2M | 0.55% |
+394,300
| New | +$17.2M |
|
|
46
BioMarin Pharmaceuticals
BMRN
$13.5B
| $15M | 0.54% |
+170,210
| New | +$14M |
|
|
ISEE
47
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $14.9M | 0.54% |
889,454
+857,689
| +2,700% | +$14.1M |
|
48
STAAR Surgical
STAA
$1.24B
| $14.7M | 0.53% |
160,974
-5,219
| -3% | -$560K |
|
|
49
PUT
STAAR Surgical
STAA
$1.24B
| $14.6M | 0.53% |
160,100
-4,900
| -3% | -$526K |
|
50
Codexis
CDXS
$159M
| $14.5M | 0.52% |
463,102
-13,068
| -3% | -$430K |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q4 2021 Portfolio in Review
As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.
- Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
- Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
- Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
- Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
- Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
- Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
- Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.
Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.